Sarcoma surgery in Spain typically costs from $31,700 to $40,000. The final price depends on the tumor location, surgical technique, and the clinic tier. In the US, similar procedures cost around $200,000 on average. Spain offers savings of around 82%. Standard costs usually include the surgical procedure, anesthesia, and initial post-operative hospital stay in cities like Barcelona, Madrid, and Pamplona.
Bookimed Expert Insight: Choosing Clinica Universidad de Navarra offers exceptional value with a 95% limb preservation rate. This center was the first Joint Commission International (JCI) accredited hospital in Spain. For pediatric cases, SJD Barcelona Children’s Hospital is a top-three European choice. They utilize advanced molecular medicine laboratories. These high-volume centers often provide better long-term outcomes for complex bone and soft tissue tumors.
Why do patients choose Spain for sarcoma surgery?
Access advanced Sarcoma surgery solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Sarcoma surgery | from $10,000 | from $35,000 | from $31,652 |
| Complex treatment of Ewing's sarcoma | from $30,000 | from $55,000 | from $35,000 |
Day 1: Arrival
Day 2: Pre-operation
Day 3: Surgery
Day 4-7: Post-operation
Week 1-2: Rehabilitation
Week 3-6: Further Rehabilitation
Week 7 onwards: Final Result
Please note that each patient"s case is individual, and the timeline can vary based on the specifics of your condition and recovery rate.
Pediatric orthopedist-traumatologist, specializes in surgical oncology
15 years of experience
Specialist in Orthopedic Surgery and Traumatology – Dr. Mikel San Julian works at Clinica Universidad de Navarra.
Over 32 years of experience specializing in pediatric oncology – Dr. Lopez Ibor leads the Pediatric Hematology and Oncology Unit at HM Monteprincipe Hospital.
The doctor is a distinguished medical oncologist with over 30 years of experience, specializing in the non-surgical treatment of genitourinary cancers, including prostate, kidney, and bladder cancers, as well as sarcomas and tumors of unknown origin. Currently, the doctor leads the Genitourinary, Central Nervous System, Sarcoma, and Unknown Origin Tumors Unit at Vall d'Hebron University Hospital in Barcelona and is affiliated with the Teknon Medical Center.
With a Ph.D. in Medicine and Surgery, the doctor has led numerous national multicenter clinical trials and has authored over 120 peer-reviewed articles. The doctor is recognized as one of Spain's leading experts in genitourinary oncology.